


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.75%
+2.03%
-4.38%
+1.23%
+1.77%
CVS
CVS Health
$80.47
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Risk Analysis

Possible liquidity concerns
Chart
$78.44 (+2.59%)
$68.6 (+17.30%)
$66.84 (+20.39%)
$57.1 (+40.93%)
CVS has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

CVS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Reported a strong earnings

Revenue increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Possible liquidity concerns

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
CVS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CVS Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is CVS current stock price?
What are CVS stock strengths?
What risks are associated with CVS stock?
When is CVS next earnings report?
What is CVS market cap and volume?
What is CVS's current Stock IQ?
Should I buy CVS stock right now?
Is CVS a Strong Buy right now?
What does a 'Strong Buy' rating mean for CVS?
What does a 'Strong Sell' rating mean for CVS?
What factors influence CVS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.75%
+2.03%
-4.38%
+1.23%
+1.77%
CVS
CVS Health
Current Price
$80.47
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Risk Analysis

Possible liquidity concerns

Chart
$78.44 (+2.59%)
$68.6 (+17.30%)
$66.84 (+20.39%)
$57.1 (+40.93%)
CVS Analysts Opinion
CVS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Reported a strong earnings

Revenue increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Possible liquidity concerns

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
CVS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CVS Street Sentiment is extremely bullish and have positive views on the near-term outlook
CVS has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
CVS Latest Analysis
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.. Key PointsCVS Health is successfully navigating industrywide and company-specific headwinds while maintaining a solid dividend program.
Wed Nov 12, 2025
Eli Lilly Drops CVS Healths Drug Benefit Plan For Employees Ahead Of 2026 Switch. ) is reportedly dropping CVS) drug benefit plan for its employees.CVS is trading near recent highs. Earlier in May this year ) announced that(semaglutide) injection 2.4 mg would be the preferredGLP-1medicine on its largest commercial .The change came into effect onJuly 1 2025.Also Read: In March Novo Nordisk launched NovoCarePharmacy to provide direct-to-patient convenient home shipments of all Wegovy dose strength
Wed Nov 12, 2025
CVS Health Lifts Adjusted EPS Outlook: Whats Driving It?. CVS raises its full-year EPS outlook after a strong quarter driven by gains across all segments and solid pharmacy growth.
Tue Nov 11, 2025
CVS Health Is Soaring 75% This Year. And the Stock Still Looks Cheap.. Key PointsCurrent CVS Health CEO David Joyner took over a little over a year ago.
Tue Nov 11, 2025
TD Cowen Maintains CVS Health (CVS) Buy Recommendation. Fintel reports that on November 3 2025 TD Cowen maintained coverage of CVS Health (NYSE:CVS) with a Buy recommendation. Analyst Price Forecast Suggests 10.28% Upside
Tue Nov 4, 2025
CVS Health: Undervalued And Ripe For Growth.
Mon Nov 3, 2025
What the Options Market Tells Us About CVS Health. High-rolling investors have positioned themselves bearish on CVS Health (NYSE:CVS) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in CVS often signals that someone has privileged information.Today Benzinga'.s options scanner spotted 9 options trade
Fri Oct 31, 2025
RBC Capital Maintains CVS Health (CVS) Outperform Recommendation. Fintel reports that on October 30 2025 RBC Capital maintained coverage of CVS Health (NYSE:CVS) with a Outperform recommendation. Analyst Price Forecast Suggests 12.77% Upside
Fri Oct 31, 2025
Cantor Fitzgerald Maintains CVS Health (CVS) Overweight Recommendation. Fintel reports that on October 30 2025 Cantor Fitzgerald maintained coverage of CVS Health (NYSE:CVS) with a Overweight recommendation. Analyst Price Forecast Suggests 12.77% Upside
Fri Oct 31, 2025
Truist Securities Reiterates CVS Health (CVS) Buy Recommendation. Fintel reports that on October 30 2025 Truist Securities reiterated coverage of CVS Health (NYSE:CVS) with a Buy recommendation. Analyst Price Forecast Suggests 12.77% Upside
Fri Oct 31, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.